NEPH - Nephros, Inc.

GypsyDRB · June 18th, 2009, 08:48 AM

I haven't seen a thread on this one over here so figured I would start one. I know some folks aren't really high on MV, but the following article wasn't written by him...just being promoted by him.

Nephros (OTC:NEPH): Three FDA Decisions, One Company |

Mahmissa · June 18th, 2009, 08:58 AM

I am sitting on NEPH shares as well. Sold off most of them at 1.66 and have rebought at 1. Will continue buying lower until we get news.

GypsyDRB · June 18th, 2009, 09:00 AM

part of me is thinking of selling all of my iCAD and buying NEPH...then rebuying iCAD. iCAD isn't going anywhere any time soon...still like the play but i think i can take advantage of the NEPH pop.

Thoughts?

Mahmissa · June 18th, 2009, 09:32 AM

My hubby and I have been talking the same craziness. Sell other things and ride NEPH. Every time I take a risk like that, I fell like things go in the opposite direction! That said. I do have buy order in for more NEPH. Lordy, lordy, I can't quit this stock

Kordoyn · June 18th, 2009, 09:36 AM

At least Neph isn't as bad as HEB.

silverspoon.paperplate · June 18th, 2009, 09:48 AM

Funny. I was looking at this one just a few hours ago.

I haven't seen the new approval date - has a new one been posted or is this the FDA limbo situation again?
Also, this may sound stupid, but are the three approvals to be simultaneous or seperate, given that they seem to be past the 90 day response time now anyway...

I just lightened up my HEB load a few days ago *winces* and am looking to add another biotech in its place.
Right now I've got NRI, CTIC and SSS...

Mahmissa · June 18th, 2009, 09:59 AM

Kordoyn, I just picked up a 1000 of HEB this am. I am losing it!!

Silver- 3 separate approvals, with separate approval dates. 510K dates are approximate and flexible, the first date just passed us by, hence the dip in the stock.

GypsyDRB · June 19th, 2009, 10:45 AM

I'm either bored and seeing things or something interesting is going on here:

When I look at the level 2 bid /ask widget in my TDA account all the asks except for the "first one" are in 500 share blocks from 1.20 up to 5 bucks with the MPID's all over the place.

Thoughts?

Mahmissa · June 19th, 2009, 11:24 AM

hmmmm.... gypsy, i'd love to hear good news about heb, bdsi or neph today!

Kordoyn · June 19th, 2009, 11:26 AM

NEPH has been a punching bag for manipulation in the last few trading sessions. I mean just look at some of those graphs, they are even more ridiculous than DNDN

GypsyDRB · June 23rd, 2009, 09:30 AM

riches2rags2 posted this on the boards that shall not be named...thought it was interesting enough to post here for those who can't/don't venture there any more

Virtual Exhibit Booths - Nephros HDF filter

GypsyDRB · June 23rd, 2009, 12:28 PM

anyone else notice this one has held strong @ its previous close price...even yesterday's price isn't very far at all from Friday's close.

Very nice...

Mahmissa · June 23rd, 2009, 12:40 PM

Yeah, I think it's levelled off. Am looking forward to good news with this.

Stealpulse · June 23rd, 2009, 01:17 PM

I got in @ $1.11 and am satisfied with the current support level. This one feels solid.

Mahmissa · June 26th, 2009, 08:08 AM

Ok, this news isn't great. Anyone buying more if the stock drops down as a result?

BRIEF-Nephros director resigns effective immediately - News - CNBC.com

NEPHROS INC Director Eric A. Rose Resigned - www.implu.com

Eric A. Rose Profile - Forbes.com

Kordoyn · June 26th, 2009, 08:16 AM

Originally Posted by Mahmissa

Ok, this news isn't great. Anyone buying more if the stock drops down as a result?

BRIEF-Nephros director resigns effective immediately - News - CNBC.com

NEPHROS INC Director Eric A. Rose Resigned - www.implu.com

Eric A. Rose Profile - Forbes.com

News is from June 24th. The stock should have reacted yesterday.

GypsyDRB · June 26th, 2009, 08:27 AM

we should send an e-mail to their investor relations dept. asking for clarification into the nature of the resignation...it may be as benign as a conflict of interest with something else he is pursuing...forced out by CEO in order to bring on new blood or due to large institutional holders wanting "their man" on the board, etc, etc.

if no one else wants to ...i will.

Mahmissa · June 26th, 2009, 08:27 AM

I know the news is a bit outdated, but it isnt coming up on Yahoo, MSN, Google etc... which I thought may have been part of the delayed response? Just a thought

GypsyDRB · June 28th, 2009, 11:52 AM

a bit dated, but worth a read...

Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the ... ( RIVER EDGE N.J. Jan. 14 /- Nephros In...)

----------------

I also sent the following e-mail to the one address I could find on the website:

Quote:

Bernie,

My name is <<redacted to protect the innocent>>. I am sending you this e-mail to inquire around the circumstances of the resignation of Eric A. Rose, M.D from the Nephros, Inc. Board of Directors. Would you please forward this on to your Investor Relations Department? There does not appear to be an e-mail listed on the website to contact them directly.

I would like to get some corporate communication as to why he resigned. For example, was he asked to resign due to poor performance or leadership? At the behest of the CEO? For personal reasons? A conflict of interest?

As a shareholder I am simply trying to keep abreast of as much information as possible.

Thank you for your time.

Adam · July 2nd, 2009, 09:26 AM

Nephros Receives 510k Approval for Dual Stage Ultrafilters
7/2/2009 9:20:00 AM ET

PR Newswire

RIVER EDGE, N.J., July 2 /PRNewswire-FirstCall/ --Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that is has received 510k approval from the U.S. FDA to market its Dual Stage Ultrafilters (DSU) for in-line purification of dialysate water and bicarbonate solution.

On July 1, 2009, Nephros received approval of the DSU to be used to filter biological contaminants from water and bicarbonate concentrate used in hemodialysis procedures.

"The DSU is Nephros's first FDA approved device in the U.S. and represents an important milestone for the company," said Ernest Elgin, President and CEO of Nephros, Inc., "within dialysis clinics, microbial and endotoxin contamination of the water and dialysate concentrate used to prepare dialysate is an ongoing concern. Nephros's DSU filters are designed to eliminate these contaminants."

Within the U.S., there are approximately 4,500 clinics providing over 50 million dialysis treatments to 350,000 patients annually. To perform dialysis, ultrapure water is crucial to the production of dialysate. Dialysis clinics have water purification systems; however, microbial contaminants can originate from the water treatment system, the water distribution loop, or the dialysate concentrates. The Nephros DSU filters particles down to the 0.005-micron level and addresses dialysate contaminants at crucial points: after the reverse osmosis module and at the dialysis machine entrance from the water distribution loop. The DSU filter can be used as the last step in the water purification process to ensure ultra pure water for dialysis procedures. Regular use of Nephros Dual Stage Ultra Filters offers an affordable safety measure when utilized with modern water treatment systems and optimally designed hemodialysis machines.